Literature DB >> 5002434

Plasma levels and urinary excretion of disodium cromoglycate afer inhalation by human volunteers.

G F Moss, K M Jones, J T Ritchie, J S Cox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5002434     DOI： 10.1016/0041-008x(71)90041-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  15 in total

1.  Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.

Authors:  O A Aswania; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

2.  Food allergy: response to treatment with sodium cromoglycate.

Authors:  J B Watson; J Timmins
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

3.  Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro.

Authors:  A Leone-Bay; H Leipold; D Sarubbi; B Variano; T Rivera; R A Baughman
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Development of an in vivo ovine dry powder inhalation model for the evaluation of conventional and controlled release microparticles.

Authors:  Rania O Salama; Leigh Ladd; Hak-Kim Chan; Daniela Traini; Paul M Young
Journal:  AAPS J       Date:  2009-07-01       Impact factor: 4.009

5.  The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration.

Authors:  M G Neale; K Brown; R W Hodder; R M Auty
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 6.  Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease.

Authors:  E M Sorkin; A Ward
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise-induced asthma: relationship to protective effect.

Authors:  K R Patel; W M Tullett; M G Neale; R T Wall; K M Tan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

8.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

9.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

10.  Disposition of disodium cromoglycate administered in three particle sizes.

Authors:  S H Curry; A J Taylor; S Evans; S Godfrey; E Zeidifard
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.